featured
Efficacy of Empagliflozin in Reducing Cognitive Impairment in Older Adults With Type 2 Diabetes and HFpEF
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
Diabetes Care 2022 Mar 14;[EPub Ahead of Print], P Mone, A Lombardi, J Gambardella, A Pansini, G Macina, M Morgante, S Frullone, G SantulliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.